On June 5, 2023, immediately following the closing of the Private Placement, the Board of Directors of Telesis Bio, Inc. was increased from seven to eight directors and Paul Meister, a partner at Novalis LifeSciences LLC, was appointed as a director of the Company to fill the resulting vacancy.